Xilio Therapeutics xiliotx.com

Xilio Therapeutics is a privately-held biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company's Aklusion platform technology allows biologics to be specifically activated in the tumor microenvironment, and with precisely tailored properties, expanding the universe of immune-activating proteins that can be safely delivered. Akrevia is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as p...Show all

Xilio Therapeutics is a privately-held biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company's Aklusion platform technology allows biologics to be specifically activated in the tumor microen...Show all

Company (Alive / Active)

All investors data 10 Investors

• Atlas Venture
• Bay City Capital
• F-Prime Capital
• Ipsen Group
• M Ventures

Board Members

Competitors

Patents